Effect of Repaglinid on Ovariectomy Induced Bone Loss in Rats: Comparison with 17β-Estradiol

dc.contributor.authorUlas, Mustafa
dc.date.accessioned2022-02-16T14:05:57Z
dc.date.available2022-02-16T14:05:57Z
dc.date.issued2017
dc.departmentİnönü Üniversitesien_US
dc.description.abstractAim: The aim of this study was to investigate the effect of repaglinide (RPG), anti-diabetic drug used commonly diabetic patients, on bone loss ovariectomized (OVX) rats”.en_US
dc.identifier.citationUlas, M. (2021). Effect of Repaglinid on Ovariectomy Induced Bone Loss in Rats: Comparison with 17β-Estradiol . Annals of Medical Research, 24(3), 0270–0273. Retrieved from https://annalsmedres.org/index.php/aomr/article/view/2168en_US
dc.identifier.doi10.5455/jtomc.2017.04.053 2017;24(3):270-3en_US
dc.identifier.urihttps://hdl.handle.net/11616/47335
dc.language.isoenen_US
dc.relation.ispartofAnnals of Medical Researchen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleEffect of Repaglinid on Ovariectomy Induced Bone Loss in Rats: Comparison with 17β-Estradiolen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
270-273.pdf
Boyut:
293.01 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: